NCT06997549 Retrospective Analyses of the Greenbrook Database Evaluating Mental Health Treatments
| NCT ID | NCT06997549 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Neuronetics |
| Condition | Depression |
| Study Type | OBSERVATIONAL |
| Enrollment | 12,000 participants |
| Start Date | 2025-05-15 |
| Primary Completion | 2035-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 12,000 participants in total. It began in 2025-05-15 with a primary completion date of 2035-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study involves multiple retrospective analyses to understand the utilization of mental health treatments provided at Greenbrook and their effectiveness
Eligibility Criteria
Inclusion Criteria: * Male or female reported in database and not an invalid entry * Age reported and not an invalid entry * Treatment date in 2011 or later. Exclusion Criteria: • Incomplete information on treatment parameters
Contact & Investigator
Eleanor Cole, PhD
STUDY DIRECTOR
Neuronetics
Frequently Asked Questions
Who can join the NCT06997549 clinical trial?
This trial is open to participants of all sexes, aged 5 Years or older, up to 100 Years, studying Depression. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06997549 currently recruiting?
Yes, NCT06997549 is actively recruiting participants. Contact the research team at neha.goyal@neurostar.com for enrollment information.
Where is the NCT06997549 trial being conducted?
This trial is being conducted at Malvern, United States.
Who is sponsoring the NCT06997549 clinical trial?
NCT06997549 is sponsored by Neuronetics. The principal investigator is Eleanor Cole, PhD at Neuronetics. The trial plans to enroll 12,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.